Clinical Infectious Diseases · 2002 · 67 citations · 7 references
MedicineInfectious Disease ControlInfectious DiseasesDisease PreventionImmunizationVaccinologyInfectious Disease PreventionVaccinationVaccination PolicyVaccine PolicyVaccine-preventable DiseasesViral VaccinesOral Polio VaccinationPoliovirus VaccinationPoliovirus VaccinesPreventive VaccinationPreventive VaccinologyVaccine AvailabilityVaccine Preventable InfectionsWorld Health Organization Vaccine Policy
After eradication, there is a small but finite risk that smallpox and/or poliomyelitis viruses could accidentally escape from a laboratory or be released intentionally. The reintroduction of either virus into a highly susceptible population could develop into a serious catastrophe. To counter such an occurrence will require the use of vaccine, perhaps in substantial quantities. In the United States, new stocks of smallpox vaccine are being procured and arrangements are being made for a standby production facility. Similar provisions need to be considered for polio. To counter an epidemic of polio will require the use of the oral vaccine, which is presently the World Health Organization-recommended vaccine of choice for countries throughout the developing world. In these countries, its continued use is advised because of its ability to induce intestinal immunity, its ability to spread to other susceptible household members and to protect them, its ease of administration, and its low cost.
7
Bulletin of the World Health Organization
Marianne A. B. van der Sande, Gijs Walraven, Paul Milligan et al. · Bulletin of the World Health Organization · 2001 · 7.2K citations · Full text
Bulletin of the World Health Organization
N. H. C. · British Journal of Sociology · 1955 · 3.7K citations
Paralytic Disease Associated With Oral Polio Vaccines
Donald A. Henderson, John Witte, Leo Morris et al. · JAMA · 1964 · 108 citations